Yahoo Web Search

Search results

1. • 

     Zydus Lifesciences concludes subject enrolment in Phase II ALS trial

     Clinical Trials Arena via Yahoo Finance· 5 days ago

     Zydus Lifesciences has announced the conclusion of subject enrolment in the Phase II clinical trial ...

2. • 

     BMS secures another EC approval for Opdivo combination

     Pharmaceutical Technology via Yahoo Finance· 4 hours ago

     GlobalData is the parent company of Pharmaceutical Technology. AstraZeneca is investigating its...

3. • 

     ...Announces Picankibart (IBI112) Achieved Primary Endpoints in a Phase 3 Clinical Trial in Treating...

     WTNH-TV New Haven· 2 days ago

     CLEAR-1 is global the first Phase 3 registration study in IL-23p19 class that reported over 80% of...

4. • 

     HI-Bio reports findings from Phase II trial in kidney transplant recipients

     Clinical Trials Arena via Yahoo Finance· 2 days ago

     Human Immunology Biosciences (HI-Bio) has reported positive outcomes from the Phase II clinical ...

5. • Panoramic Health Elevates Kidney Care Innovation With Appointment of Dr. Navdeep Tangri as Senior...

     Digital Journal· 4 hours ago

     Vienna ball season back in full swing ‘Avatar 2’ success proves cinema in post-pandemic ‘resurgence’: Cameron North of Soledar, Ukrainians yearn for peace Carlo Marks talks ...

6. • ...Bioscience Announces First Patient Dosed in Phase 1/2 Clinical Trial of TSN1611, a Selective and...

     Benzinga· 5 days ago

     SHANGHAI, May 24, 2024 /PRNewswire/ -- Tyligand Bioscience, a clinical-stage biotechnology company focused on the discovery and development of innovative ...

7. • NRx Pharmaceuticals (Nasdaq:NRXP) Presents Landmark Trial of NRX-101 in Suicidal Bipolar Depression...

     WTNH-TV New Haven· 1 day ago

     ...demonstrated a similar antidepressant effect (MADRS reduction ~50%) compared to lurasidone, the Standard of Care drugNRX-101 demonstrated a 58% relative reduction in time to sustained remission from suicidality (P=.05) compared to lurasidoneNRX-101 demonstrated a 76% reduction in symptoms of...

8. • 

     NS Pharma reports data from Phase III Duchenne treatment trial

     Clinical Trials Arena via Yahoo Finance· 1 day ago

     Similar trends were also observed in the placebo group, resulting in no statistically significant...

9. • ...Medical Announces Recent Interim Data from Phase 1b/2 Clinical Trial of ASP-1929...

     FOX 5 San Diego· 5 days ago

     The data will be presented in a poster at the 2024 American Society of Clinical Oncology Annual Meeting (ASCO 2024) on June 2, 2024.

10. • 

      Sanofi reports positive data from Phase II asthma treatment trial

      Clinical Trials Arena via Yahoo Finance· 6 days ago

      Sanofi has announced positive outcomes from a Phase II clinical trial of rilzabrutinib, an oral...